Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Moodys
McKinsey
Julphar
Fuji
Chinese Patent Office
US Department of Justice
Deloitte
Cipla
Dow

Generated: February 18, 2018

DrugPatentWatch Database Preview

ESTAZOLAM Drug Profile

« Back to Dashboard

When do Estazolam patents expire, and what generic alternatives are available?

Estazolam is a drug marketed by Mayne Pharma, Par Pharm, and Watson Labs. and is included in three NDAs.

The generic ingredient in ESTAZOLAM is estazolam. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estazolam profile page.
Drug patent expirations by year for ESTAZOLAM
Pharmacology for ESTAZOLAM
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for ESTAZOLAM

US Patents and Regulatory Information for ESTAZOLAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma ESTAZOLAM estazolam TABLET;ORAL 074921-001 Jul 10, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm ESTAZOLAM estazolam TABLET;ORAL 074826-002 Jul 3, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mayne Pharma ESTAZOLAM estazolam TABLET;ORAL 074921-002 Jul 10, 1997 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm ESTAZOLAM estazolam TABLET;ORAL 074826-001 Jul 3, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs ESTAZOLAM estazolam TABLET;ORAL 074818-002 Aug 19, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs ESTAZOLAM estazolam TABLET;ORAL 074818-001 Aug 19, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
Healthtrust
Moodys
McKinsey
Deloitte
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot